Embolization: Selected Procedures — CPB 0856 | AETNA Coverage Update

Aetna modified CPB 0856 governing embolization coverage, effective January 14, 2026. Here's what billing teams need to know before submitting claims under CPT 37241–37244, 61624, 61626, and 75894.

Aetna, a CVS Health company, updated Clinical Policy Bulletin 0856 to clarify which embolization procedures meet medical necessity and which remain experimental or unproven. This coverage policy covers a wide range of indications — from geniculate artery embolization after total knee arthroplasty to transcatheter embolization for gastrointestinal bleeding — and the distinctions between covered and non-covered procedures are specific enough that one wrong diagnosis code or missing criterion will generate a claim denial.

If your practice or facility bills any embolization procedure to Aetna, audit your charge capture and documentation workflows against the updated criteria now.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna, a CVS Health company
Policy	Embolization: Selected Procedures
Policy Code	CPB 0856
Change Type	Modified
Effective Date	January 14, 2026
Impact Level	High
Specialties Affected	Interventional radiology, vascular surgery, neurosurgery, orthopedic surgery, gastroenterology, urology, otolaryngology
Key Action	Audit active embolization cases against CPB 0856 criteria; confirm documentation meets each indication's specific requirements before billing CPT 37241–37244

---

Aetna Embolization Coverage Criteria and Medical Necessity Requirements 2026

The CPB 0856 Aetna embolization coverage policy lists 17 covered indications. Each one carries its own clinical threshold. Meeting the general diagnosis isn't enough — your documentation must hit the specific criteria for that indication.

Vascular malformations and aneurysms are broadly covered. Alcohol embolization or sclerotherapy for symptomatic venous malformations is covered when members show pain, swelling, ulceration, or hemorrhage. Coil embolization is covered for arteriovenous malformations (AVMs), aneurysms, congenital aorto-azygous fistulas, and splenic artery aneurysms. Endovascular embolization covers extracranial AVMs and fistulas.

Gastrointestinal bleeding gets detailed treatment in this coverage policy. Aetna covers transcatheter arterial embolization for non-variceal upper GI bleeding. For lower GI bleeding, the bar is higher. A bleeding scan must confirm the lower GI tract as the source, and one of three criteria must be met: the patient is hemodynamically unstable or required more than four units of blood within 24 hours; colonoscopy localized the bleeding site and treatment was attempted; or the patient has obscure recurrent lower GI bleeding after a prior negative adequate colonoscopy and upper gastrointestinal endoscopy.

Geniculate artery embolization for knee hemarthrosis after total knee arthroplasty is covered — but only after failed conservative therapies. Aetna's list includes ice, immobilization, compression, saline lavage, corticosteroid instillation, and selective COX-2 inhibitors. Synovial hyper-vascularity must be confirmed on angiography. If your documentation doesn't address each of these items, expect a claim denial.

Renal conditions carry a size threshold you can't ignore. Embolization for renal angiomyolipoma (AML) — using coil, microsphere, glue, or other agents — is covered only if there's active bleeding or the AML exceeds 6 cm. For renal cell carcinoma, renal artery embolization is covered as a pre-operative adjunct to nephrectomy in large, hyper-vascular tumors.

Tumor and pre-operative indications are covered under the embolization CPT codes as applicable. Tumor embolization or pre-operative embolization to reduce intra-operative bleeding is covered for hyper-vascular tumors or hyper-vascular metastases. Pre-operative embolization of skull base meningiomas is also covered. Portal vein embolization before cholangiocarcinoma resection qualifies as medically necessary.

Other covered indications include: coil embolization of gastric varices (ICD-10 I86.4), splenic artery embolization for hypersplenism secondary to hepatic cirrhosis (D73.1) as an alternative to splenectomy, selective arterial embolization for giant cell tumor (D16.x), and vascular embolization for type I or type II endovascular leak. Transcatheter embolization for intractable or recurrent severe posterior epistaxis is covered when conservative measures have failed.

Medical necessity documentation must be specific and condition-matched. Generic procedural notes won't hold up under review. If prior authorization is part of your standard workflow for these cases, confirm the authorization request matches the exact covered indication — not just the procedure type.

---

Aetna Embolization Exclusions and Non-Covered Indications

Aetna's experimental and investigational list under CPB 0856 is long. These procedures will not get reimbursement under the current policy, regardless of the clinical rationale in your notes.

Denied as experimental: Coil embolization of hypogastric veins for DVT prevention or treatment. Coil embolization for left ventricular outflow tract (LVOT) pseudoaneurysm (ICD-10 I71.21). Embolization for locoregional treatment of metastatic pancreatic cancer. Embolization for asymptomatic persistent sciatic artery. Embolization of a stealing vein branch for subclavian steal syndrome (G45.8).

Also denied: Embolization or stenting of sigmoid sinus or jugular bulb diverticulum for pulsatile tinnitus (H93.A1–H93.A9). Endovascular embolization for spinal dural arteriovenous fistula. Endovascular lymphatic ablation for protein-losing enteropathy (K90.49). Genicular artery embolization — note that this appears truncated in the policy summary, but the pattern is clear.

The real issue here is the overlap risk. Genicular artery embolization for knee hemarthrosis post-arthroplasty is covered. But adjacent indications — like embolization for knee osteoarthritis pain (M17.x) — fall into different territory. If your documentation doesn't tie directly to the covered indication with its required criteria, Aetna will treat it as not medically necessary or experimental.

If you bill embolization for any of these non-covered indications, talk to your compliance officer before the effective date of January 14, 2026.

---

Coverage Indications at a Glance

CPT code selection requires clinical determination. CPB 0856 does not assign specific CPT codes to individual indications. The applicable codes across this policy are CPT 37241, 37242, 37243, 37244, 61624, 61626, and 75894 — use the code that matches the procedure performed and the clinical context. The ICD-10 codes below are drawn directly from CPB 0856.

---

Aetna Embolization Billing Guidelines and Action Items 2026

The billing guidelines for CPB 0856 demand specific documentation, not general clinical notes. Here's what your team needs to do before January 14, 2026 — and on every claim after.

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for Embolization Under CPB 0856

Covered CPT Codes (When Selection Criteria Are Met)

Note: CPB 0856 lists these codes as covered when selection criteria are met. The policy does not assign specific codes to specific indications. CPT code selection requires clinical determination based on the procedure performed.

Key ICD-10-CM Diagnosis Codes

---